Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebo-controlled trial.

Background And Purpose: Evidence of drug efficacy in vascular dementia (VaD) is scanty. Therapeutic trials should address VaD subtypes. We studied the efficacy and safety of the calcium antagonist nimodipine in subcortical VaD.